Ribonucleotide reductase: an old target with new potential

被引:72
作者
Smith, BD [1 ]
Karp, JE [1 ]
机构
[1] Johns Hopkins, Sidney Kimmel Canc Ctr, Baltimore, MD 21210 USA
关键词
D O I
10.1016/S0145-2126(03)00248-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
[No abstract available]
引用
收藏
页码:1075 / 1076
页数:2
相关论文
共 10 条
[1]
Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia [J].
Crews, KR ;
Gandhi, V ;
Srivastava, DK ;
Razzouk, BI ;
Tong, X ;
Behm, FG ;
Plunkett, W ;
Raimondi, SC ;
Pui, CH ;
Rubnitz, JE ;
Stewart, CF ;
Ribeiro, RC .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (20) :4217-4224
[2]
Comparison of idarubicin plus ara-C-, fludarabine plus ara-C-, and topotecan plus ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts [J].
Estey, EH ;
Thall, PF ;
Cortes, JE ;
Giles, FJ ;
O'Brien, S ;
Pierce, SA ;
Wang, XM ;
Kantarjian, HM ;
Beran, M .
BLOOD, 2001, 98 (13) :3575-3583
[3]
Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone; 3-AP), an inhibitor of ribonucleotide reductase with antineoplastic activity [J].
Finch, RA ;
Liu, MC ;
Cory, AH ;
Cory, JG ;
Sartorelli, AC .
ADVANCES IN ENZYME REGULATION, VOL 39, 1999, 39 :3-12
[4]
Liu Hong, 1996, Tokushima Journal of Experimental Medicine, V43, P107
[5]
MANN GJ, 1988, CANCER RES, V48, P5151
[6]
McCarthy AJ, 1999, MED PEDIATR ONCOL, V32, P411, DOI 10.1002/(SICI)1096-911X(199906)32:6<411::AID-MPO3>3.0.CO
[7]
2-K
[8]
RAUSCHER F, 1983, CANCER RES, V43, P2688
[9]
RIBONUCLEOTIDE REDUCTASE - A RADICAL ENZYME [J].
REICHARD, P ;
EHRENBERG, A .
SCIENCE, 1983, 221 (4610) :514-519
[10]
Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML [J].
Steinmetz, HT ;
Schulz, A ;
Staib, P ;
Scheid, C ;
Glasmacher, A ;
Neufang, A ;
Franklin, J ;
Tesch, H ;
Diehl, V ;
Wickramanayake, PD .
ANNALS OF HEMATOLOGY, 1999, 78 (09) :418-425